Guggenheim’s Seamus Fernandez cut his rating on Novo Nordisk stock to Hold from Buy on Thursday, as did Evan David Seigerman ...

Shares of Novo Nordisk, the Danish pharmaceutical company behind weight-loss drugs Ozempic and Wegovy, plummeted this week.

In a new First Opinion essay, Borio and Krause, both once top FDA officials, say the commissioner made a “rookie misstep” in ...

Eli Lilly & Co.'s stock soared 14% Thursday, to put it on track for its biggest one-day gain in about 25 years, after the drugmaker reported positive results from a late-stage trial of a GLP-1 ...

A North Texas hospital system has filed a lawsuit over insulin pricing, joining a growing rank of plaintiffs who are suing manufacturers and others on the grounds of inflating prices of the vital drug ...

Patients with obesity often report being shamed and stigmatized in medical settings. How can physicians address weight ...